Literature DB >> 1577411

Transforming growth factor alpha expression in normal gastric mucosa, intestinal metaplasia, dysplasia and gastric carcinoma--an immunohistochemical study.

M M Nasim1, D M Thomas, M R Alison, M I Filipe.   

Abstract

Using a monoclonal antibody (GF10) and a standard immunohistochemical technique, immuno-expression of transforming growth factor alpha (TGF-alpha) was found consistently within the differentiated compartment of normal adult human gastric mucosa. In 70% of mucosal samples exhibiting intestinal metaplasia there was more or less uniform TGF-alpha immunoreactivity throughout the intestinalized mucosa. Similarly, 60% of cases of dysplasia and 60% of gastric carcinomas showed strong immunoreactivity in most of the cells. However, whereas 93% of intestinal-type cancers showed strong immunoreactivity only 30% of the diffuse type were stained and then only weakly. Transforming growth factor alpha expression is thus a fairly regular feature of several types of differentiated gastric epithelia (normal, metaplastic, dysplastic and intestinal-type carcinoma), while its relative absence may be a factor in the histogenesis of the diffuse type of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577411     DOI: 10.1111/j.1365-2559.1992.tb00991.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa.

Authors:  S Abe; H Sasano; K Katoh; S Ohara; T Arikawa; T Noguchi; S Asaki; W Yasui; E Tahara; H Nagura; T Toyota
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Proliferation of osteoclast-like giant cells in a metastatic bone tumor from stomach cancer: report of a case and analysis of the autopsy findings.

Authors:  T Saeki; K Mandai; S Moriwaki; K Yamagami; N Sakamoto; W Takiyama; S Takashima
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Proprotein-processing endoprotease furin controls the growth and differentiation of gastric surface mucous cells.

Authors:  Y Konda; H Yokota; T Kayo; T Horiuchi; N Sugiyama; S Tanaka; K Takata; T Takeuchi
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 4.  Molecular biology and gastric carcinoma.

Authors:  P A Wright; G T Williams
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

5.  Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus.

Authors:  S Koyama; K Ikeda; M Sato; K Shibahara; K Yuhara; H Fukutomi; K Fukunaga; N Kanazawa; K Yuzawa; K Fukao; T Iijima; M Kikuchi; T Tomiya; K Fujiwara
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

6.  Immunolocalization of transforming growth factor-alpha and epidermal growth factor receptor in the rat gastroduodenal area.

Authors:  B Montaner; M Asbert; R Pérez-Tomás
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

7.  Expression of transforming growth factor alpha in experimental gastric carcinogenesis.

Authors:  J I Livingstone; M I Filipe; C Wastell
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

8.  Transforming growth factor-alpha is a constant component of human tear fluid.

Authors:  G van Setten; G Schultz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

9.  Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury.

Authors:  Takashi Kosone; Hitoshi Takagi; Satoru Kakizaki; Naondo Sohara; Norio Horiguchi; Ken Sato; Masashi Yoneda; Toshiyuki Takeuchi; Masatomo Mori
Journal:  BMC Gastroenterol       Date:  2006-08-01       Impact factor: 3.067

10.  Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.

Authors:  M I Filipe; M Osborn; J Linehan; E Sanidas; M J Brito; J Jankowski
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.